http://archive.fast-edgar.com/20260924/AQ22U22GZ22RQ2Z2222622YSFHOMYZ223282
Filed on: September 24, 2026
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of September, 2026
Commission File Number: 001-12518
Banco Santander, S.A.
(Exact name of registrant as specified in its charter)
Ciudad Grupo Santander
28660 Boadilla del Monte (Madrid) Spain
(Address of principal executive office)
Indicate... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number 001-33098
Mizuho Financial Group, Inc.
(Translation of registrant’s name into English)
5-5, Otemachi 1-chome
Chiyoda-ku, Tokyo 100-8176
Japan
(Address of principal executive office)
Indicate by check mark... (continue reading...)
Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration Statement No. 333-297820
Relating to the
Preliminary Prospectus Supplements
Dated September 23, 2026
(To Prospectus Dated July 29, 2026)
PRICING TERM SHEET
September 23, 2026
Viking Therapeutics, Inc.
Offerings of
7,857,143 Shares of Common Stock
and
$225,000,000 Aggregate Principal Amount of
2.00% Convertible Senior Notes due 2032
The information in this pricing term... (continue reading...)
More SEC Filings
View Older Stories-
Form 497K Nushares ETF Trust
-
Form 4 ASE Technology Holding For: Sep 22 Filed by: Chang Hung Pen
-
Form 485BXT GraniteShares ETF Trust
-
Form 8-K TruGolf Holdings, Inc. For: Sep 22
-
Form 497 Nushares ETF Trust
-
Form PRER14A Utz Brands, Inc.
-
Form 485BXT GraniteShares ETF Trust
-
Form 6-K TAIWAN SEMICONDUCTOR For: Aug 31
-
Form 485BXT GraniteShares ETF Trust
-
Form EFFECT New Carlyle Credit Solut
-
Form EFFECT GeoVax Labs, Inc.
-
Form EFFECT J-Star Holding Co., Ltd.
-
Form C/A Craftee Tri-Channel Drop
-
Form EFFECT Hyperliquid Strategies
-
Form D NeoDomes, Inc.
-
Form 485BPOS iM Global Partner Funds
-
Form EFFECT Polomar Health Services,
-
Form 424B3 New Carlyle Credit Solut
-
Form EFFECT RUI Holdings Inc
-
Form 6-K SEQUANS COMMUNICATIONS For: Sep 24
-
Form EFFECT AGILENT TECHNOLOGIES,
-
Form EFFECT MapLight Therapeutics,
-
Form SF-1 WHEELING POWER CO
-
Form SF-1 APPALACHIAN POWER CO
-
Form 1-A XChange Ventures, LLC
-
Form EFFECT INTELLIGENT BIO SOLUTION
-
Form EFFECT Radiopharm Theranostics
-
Form QUALIF Park View OZ REIT Inc
-
Form 8-K Artificial Intelligence For: Sep 24
-
Form 8-K Jaguar Health, Inc. For: Sep 23
-
Form 144 Qfin Holdings, Inc. Filed by: Yan Andrew Y
-
Form 8-K GROUP 1 AUTOMOTIVE INC For: Sep 23
-
Form 8-K Kyverna Therapeutics, For: Sep 24
-
Form SC TO-I UTAH MEDICAL PRODUCTS Filed by: UTAH MEDICAL PRODUCTS INC
-
Form 6-K Caledonia Mining Corp For: Sep 24
-
Form F-4 Inobat B.V.
-
Form S-1/A Evolution Metals & Techn
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D LIONHEART HA SPV I, LP
-
Form 305B2 Viking Therapeutics,
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Wander-x LLC
-
Form 6-K Lufax Holding Ltd For: Sep 23
-
Form 424B2 ROYAL BANK OF CANADA
-
Form N-2/A DoubleLine Yield Opportu
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 10-K AtlasClear Holdings, For: Jun 30
-
Form 8-K Lantern Pharma Inc. For: Sep 23
-
Form 6-K Lion Group Holding Ltd For: Sep 23

